PZU Calls Vote on LINK4 Merger, Transferring All Assets by First Quarter of 2027
Key Facts
PZU called on shareholders to attend an extraordinary general meeting on November 24, 2026, to vote on merging LINK4, according to a regulatory notice issued by the company and reported by PAP MediaRoom. The plan calls for all LINK4 assets to be transferred to PZU in a legal merger requiring resolutions from the general meetings of both companies. PZU owns 100% of LINK4 and said it is the company’s sole shareholder. The vote is therefore part of the procedures to carry out a transaction between two subsidiaries of the group, rather than final approval of a new acquisition. The materials available for the meeting did not include an assessment of the suitability of members of the supervisory board.
Under the plan, PZU will not need to increase its share capital or amend its articles of association because of the merger. This differs from a transaction requiring the issuance of new shares or a change to the company’s founding rules; the notice identifies the transfer of assets as the merger mechanism. Resolutions by both companies’ general meetings remain an institutional requirement for the transaction, as the merger requires a decision by shareholders of each company. The management boards of PZU and LINK4 signed the merger plan on May 29, 2026, placing the November meeting within a process that began with the boards’ agreement on the plan. PZU’s full ownership structure allows it to vote on merging its subsidiary within this institutional framework.
PZU links the transaction to its 2025–2027 strategy, which aims to simplify the group’s structure, increase operating efficiency and develop a multi-brand model. The company presents these aims as organizational and operational reasons for the merger, while the transfer of LINK4’s assets to PZU is the specific legal form set out in the plan. PZU said the planned merger would have no material impact on the group’s consolidated financial statements. This assessment limits expectations of a material change in the consolidated statements due to the transaction alone, according to the company’s financial statements for the first quarter of 2026. The available materials did not provide a separate quantitative estimate of the financial impact.
PZU made the merger documents, financial statements, management reports and audit reports for both companies for the 2023, 2024 and 2025 financial years available at its headquarters, starting on October 23, 2026, until the end of the respective general meetings. The materials cover consecutive financial years from 2023 to 2025, enabling shareholders to review documents from both parties before voting. The consolidated third-quarter 2026 financial report is scheduled for release on November 19, according to the investor relations calendar, five days before the meeting. The report will therefore precede the vote directly in the sequence of events announced to shareholders. The extraordinary meeting is scheduled for November 24.
PZU expects to complete the merger by the first quarter of 2027, subject to fulfilling legal, regulatory and corporate requirements and obtaining the necessary approvals. This means the vote scheduled for November will take place before the expected completion date, while the required steps remain contingent on meeting those requirements. The company set the first-quarter 2027 timing in its consolidated financial statements for the first quarter of 2026, as a conditional forecast. The announced implementation process is based on the merger plan signed by the management boards on May 29, 2026, and on resolutions by the general meetings. Completion of the transaction remains contingent on meeting the stated conditions before the end of the first quarter of 2027.